Cellements has developed a strong business model that takes these impressive products from the pharmacies and vaccination clinics to the average consumer through its Direct Selling Partners.
The company has started to accept orders and signups from Partners & Customers in USA:
CEO Anders Karlsson said:
We believe in the biggest Direct Sales Market of the world and also value the historic aspect of that the concept was developed in US.
Our category of products fit into a marketplace where more and more people think about prevention and getting sick is either not an option (you might have to work anyway) or very expensive.
Most companies grow from US into Asia, Latin/South America and other countries from US. We look forward in supporting US leaders in building a global business with Cellements spreading around the globe.
We have several parallel projects regarding the US market running. We are working on setting up an entity in Arizona (estimated to be ready mid May), Working on merchant account after that to accept USD and be able to pay out USD with no currency conversion.
We ordered first 40,000 AntiBac Sprays with FDA complaint label (another active ingredient will be lifted for the US market that is already registered in
Tag Archive for Anders Karlsson
Hot Business News Today
Cellelements Launches In Europe
by Ted Nuyten • • 0 Comments
Cellements is a privately held Estonian Direct Sales company founded in 2017 by its CEO Anders Karlsson and partners.
With its global headquarters strategically located in the city of Tallinn, it is well positioned within the European Union to provide first class services to the entire region. Additional plans are underway to open its first international branch office in the United States by January 2018.
Cellements has assembled a very seasoned management team comprised of individuals with decades of experience both inside the corporate world together with those who have been successful in the field. One of Cellements key team members is that of Global Vice President, Ben Thibaudeau.
He will be responsible for overseeing Cellement’s global operations and its aggressive expansion strategy. He brings over 17 years of hands on experience working with some of the biggest public and private companies in the industry.
Additionally, Cellements recently acquired a very prominent Swedish Research and Development company by the name of Hygiene of Sweden. This biotech company’s sole focus is to develop both environmentally and user friendly products for the average consumer.
Heading up Cellements’ R&D department is Swedish bioscientist Philip Wilhelmsson. Philip has been recognized on numerous occasions for his innovative approach to developing